Medicenna Therapeutics Corp. (MDNAF)
OTCMKTS · Delayed Price · Currency is USD
0.6100
-0.0040 (-0.65%)
Jul 24, 2025, 4:00 PM EDT

Medicenna Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jul '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
5153964573215
Upgrade
Market Cap Growth
-44.25%-44.25%111.19%-38.33%-65.83%80.82%
Upgrade
Enterprise Value
3333801955189
Upgrade
Last Close Price
0.610.681.370.631.284.08
Upgrade
PB Ratio
3.854.0124.952.084.407.09
Upgrade
P/TBV Ratio
3.864.0325.232.084.427.10
Upgrade
Debt / Equity Ratio
0.010.01---0.00
Upgrade
Quick Ratio
6.216.216.344.958.339.93
Upgrade
Current Ratio
6.356.356.665.238.9210.26
Upgrade
Return on Equity (ROE)
-97.22%-97.22%-146.88%-39.94%-76.56%-46.54%
Upgrade
Return on Assets (ROA)
-53.68%-53.68%-42.00%-34.02%-42.75%-27.10%
Upgrade
Return on Capital (ROIC)
-104.31%-104.31%-67.31%-40.50%-47.60%-29.23%
Upgrade
Earnings Yield
-16.06%-15.40%-19.66%-16.40%-24.62%-6.40%
Upgrade
FCF Yield
-22.48%-21.56%-12.55%-20.65%-25.72%-5.66%
Upgrade
Buyback Yield / Dilution
-10.10%-10.10%-7.57%-19.25%-9.31%-55.68%
Upgrade
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.